Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NoTOPain
2015-001195-21Phase 2Completed
- Sponsor
- Sørlandet sykehus
- Start
- Jul 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Neuralgia, radiculalgia and complex regional pain syndrome (CRPS) comparing Cetuximab (Erbitux) arm with Placebo arm (2 arms). Primary endpoint: Mean difference in average daily pain scores. Started Jul 2015; status: completed.
02
Drugs
cetuximab
03
Conditions
Neuralgiaradiculalgiacomplex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on 2015-001195-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001195-21.